News
Cell and Gene Therapy Catapult welcomes new non-executive directors
The Cell and Gene Therapy Catapult (CGT Catapult), an independent innovation and technology organisation specialising in the advancement of the cell and gene therapy...
Locate Bio raises £9.2m to progress LDGraft clinical study for anterior lumbar interbody fusion
Locate Bio, an orthobiologics company, has successfully completed an oversubscribed £9.2 million funding round from both new investors and existing investors, Mercia Ventures and...
Incyte to acquire Escient Pharmaceuticals
Incyte and Escient Pharmaceuticals, a clinical-stage drug discovery and development company advancing novel small molecule therapeutics for systemic immune and neuro-immune disorders, have entered...
